Icu Medical Inc/De
—- Market cap
- $4.19B
- Debt
- +$1.28B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 77% equity / 23% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: ICUI stock price vs CROX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CROX's multiple
Needs CROX P/E.
Implied fair value · at ICUI's multiple
Needs EPS (TTM) is negative, ICUI P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ICUI FY 2025 (ended Dec 31, 2025) · CROX FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 77% equity / 23% debt
Capital structure 82% equity / 18% debt · EV / Revenue 1.67x · EV / EBITDA 29.29x
CROX carries the larger enterprise value at $6.74B against $5.48B; CROX trades on the lower EV / Revenue multiple (1.67x vs 2.45x); ICUI on the lower EV / EBITDA (13.54x vs 29.29x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ICU MEDICAL INC/DE · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
CROCS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.60x
0.95x
Net debt / EBITDA
Leverage against operating earnings
—
4.79x
Cash and equivalents
Liquid reserves on the balance sheet
—
$130.35M
Total debt
Interest-bearing obligations outstanding
$1.28B
$1.23B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.